TD Waterhouse Canada Inc. Sells 30,066 Shares of McKesson Corporation $MCK

Posted by Geri Gentry on Sep 4th, 2026

TD Waterhouse Canada Inc. cut its position in McKesson Corporation (NYSE:MCK – Free Report) by 23.6% during the second quarter, Holdings Channel.com reports. The institutional investor owned 97,415 shares of the company’s stock after selling 30,066 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in McKesson were worth $74,900,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MCK. University of Texas Texas AM Investment Management Co. acquired a new stake in shares of McKesson during the fourth quarter worth approximately $25,000. Swiss RE Ltd. acquired a new position in shares of McKesson in the 4th quarter worth approximately $26,000. Delos Wealth Advisors LLC acquired a new position in shares of McKesson in the 2nd quarter worth approximately $27,000. State of Wyoming bought a new stake in McKesson during the 2nd quarter worth approximately $29,000. Finally, Kingdom Financial Group LLC. bought a new stake in McKesson during the 4th quarter worth approximately $33,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

McKesson Trading Down 0.3%

Shares of NYSE MCK opened at $921.70 on Friday. The firm has a market capitalization of $107.46 billion, a PE ratio of 24.66, a price-to-earnings-growth ratio of 1.84 and a beta of 0.30. McKesson Corporation has a 1 year low of $682.35 and a 1 year high of $999.00. The firm’s 50-day moving average is $845.27 and its 200-day moving average is $842.63.

McKesson (NYSE:MCK – Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, topping analysts’ consensus estimates of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The business had revenue of $105.38 billion during the quarter, compared to the consensus estimate of $103.88 billion. During the same period in the previous year, the firm posted $8.26 earnings per share. McKesson’s revenue for the quarter was up 7.7% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, equities research analysts anticipate that McKesson Corporation will post 44.65 earnings per share for the current fiscal year.

McKesson Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be given a dividend of $0.94 per share. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Tuesday, September 1st. This is a positive change from McKesson’s previous quarterly dividend of $0.82. McKesson’s dividend payout ratio is presently 10.06%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on MCK shares. Weiss Ratings downgraded McKesson from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, July 7th. JPMorgan Chase & Co. decreased their target price on McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating on the stock in a report on Friday, May 8th. Robert W. Baird set a $1,015.00 target price on McKesson in a research note on Thursday, August 6th. Evercore reaffirmed an “outperform” rating on shares of McKesson in a report on Thursday, August 6th. Finally, Morgan Stanley reiterated an “overweight” rating on shares of McKesson in a research report on Friday, August 7th. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $973.44.

Get Our Latest Stock Analysis on MCK

Insider Buying and Selling at McKesson

In other news, Director Bradley Lerman sold 301 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $892.33, for a total value of $268,591.33. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Brian Tyler sold 8,463 shares of the firm’s stock in a transaction on Tuesday, July 7th. The stock was sold at an average price of $793.56, for a total value of $6,715,898.28. Following the completion of the transaction, the chief executive officer owned 5,919 shares in the company, valued at $4,697,081.64. This represents a 58.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,156 shares of company stock valued at $17,305,242 in the last quarter. Corporate insiders own 0.06% of the company’s stock.

About McKesson

(Free Report)

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.